Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion type Assertion NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_head.
- NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion description "[A progressive disease after chemotherapy completion was noted in 35.6% of the patients (26 out of 73); in 69.2%, a mutated p53 and in 30.8%, a wild-type p53 was found.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_provenance.
- NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion evidence source_evidence_literature NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_provenance.
- NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion SIO_000772 19609560 NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_provenance.
- NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion wasDerivedFrom befree-20150227 NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_provenance.
- NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_assertion wasGeneratedBy ECO_0000203 NP755013.RAebvz9l90nZcKOw2WfnTiF5xluQKWZ5oiW_C-HFWHSV8130_provenance.